OPKO Health, Inc.
NASDAQ:OPK
1.57 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 863.495 | 1,004.2 | 1,774.7 | 1,435.4 | 901.9 | 990.3 | 966.006 | 1,221.7 | 491.7 | 91.1 | 96.53 | 47.044 | 27.979 | 28.494 | 13.147 | 9.44 | 0.847 | 0 | 0 | 0 | 0.013 | 0.562 | 1.333 | 0.865 | 1.375 | 1.2 | 0.1 | 0.1 | 0.1 |
| Cost of Revenue
| 631.4 | 716 | 1,193.2 | 894.4 | 572.5 | 604.6 | 620.13 | 611.5 | 590.2 | 236.9 | 48.86 | 27.878 | 17.243 | 13.495 | 9.567 | 8.559 | 0.808 | 0 | 0 | 0 | 0 | 0 | 0 | -0.29 | -0.2 | -0.1 | -0.1 | -0.1 | 0.5 |
| Gross Profit
| 232.095 | 288.2 | 581.5 | 541 | 329.4 | 385.7 | 345.876 | 610.2 | -98.5 | -145.8 | 47.67 | 19.166 | 10.736 | 14.999 | 3.58 | 0.881 | 0.039 | 0 | 0 | 0 | 0.013 | 0.562 | 1.333 | 1.155 | 1.575 | 1.3 | 0.2 | 0.2 | -0.4 |
| Gross Profit Ratio
| 0.269 | 0.287 | 0.328 | 0.377 | 0.365 | 0.389 | 0.358 | 0.499 | -0.2 | -1.6 | 0.494 | 0.407 | 0.384 | 0.526 | 0.272 | 0.093 | 0.046 | 0 | 0 | 0 | 1 | 1 | 1 | 1.335 | 1.145 | 1.083 | 2 | 2 | -4 |
| Reseach & Development Expenses
| 89.593 | 73.9 | 76.8 | 75.3 | 117.9 | 125.6 | 126.435 | 111.2 | 99.488 | 83.571 | 53.902 | 19.52 | 11.352 | 5.949 | 12.881 | 21.562 | 10.85 | 0 | 0 | 0 | 0.154 | 3.948 | 5.321 | 3.681 | 2.332 | 1.7 | 1.5 | 1.6 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.117 | 1.438 | 2.051 | 2.938 | 0 | 6.53 | 5.788 | 3.194 | 2.5 | 1.9 | 1.5 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.653 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 300.559 | 372.7 | 468.9 | 355.6 | 343.3 | 358.4 | 414.628 | 490.9 | 196.576 | 57.94 | 55.32 | 27.795 | 19.169 | 18.133 | 13.518 | 14.79 | 12.466 | 1.117 | 1.438 | 2.051 | 3.591 | 5.634 | 6.53 | 5.788 | 3.194 | 2.5 | 1.9 | 1.5 | 1.1 |
| Other Expenses
| -16.994 | 87.8 | 50.3 | 56.4 | 64.8 | -6 | 10.457 | -0.2 | -39.5 | -25.2 | 25.329 | 1.273 | 3.404 | 3.579 | 3.201 | 1.694 | 0.821 | 0 | 0 | 0 | 0 | 0 | 0 | 0.29 | 0.2 | 0.1 | 0.1 | 0.1 | 0.7 |
| Operating Expenses
| 390.152 | 534.4 | 596 | 487.3 | 526 | 551.9 | 625.741 | 666.5 | 349.93 | 152.43 | 120.355 | 55.65 | 33.925 | 26.135 | 29.6 | 38.046 | 24.137 | 1.117 | 1.438 | 2.051 | 3.745 | 9.582 | 11.851 | 9.759 | 5.726 | 4.3 | 3.5 | 3.2 | 1.8 |
| Operating Income
| -158.057 | -246.2 | -47.7 | 57.7 | -196.6 | -171.2 | -276.442 | -73.3 | -98.5 | -145.8 | -79.632 | -37.269 | -23.189 | -11.136 | -28.02 | -38.563 | -267.859 | -1.117 | -1.438 | -2.051 | -3.732 | -9.02 | -10.518 | -8.604 | -4.151 | -3 | -3.3 | -3 | -2.2 |
| Operating Income Ratio
| -0.183 | -0.245 | -0.027 | 0.04 | -0.218 | -0.173 | -0.286 | -0.06 | -0.2 | -1.6 | -0.825 | -0.792 | -0.829 | -0.391 | -2.131 | -4.085 | -316.244 | 0 | 0 | 0 | -287.077 | -16.05 | -7.89 | -9.947 | -3.019 | -2.5 | -33 | -30 | -22 |
| Total Other Income Expenses Net
| -26.262 | -145.3 | 33.7 | -9 | -108.3 | -11 | 13.932 | -17.2 | -39.5 | -25.2 | -18.107 | 0.488 | -0.327 | -0.844 | -4.034 | -1.398 | -245.211 | 0.469 | 1.064 | 0.125 | -2.233 | -2.006 | 0.274 | 1.534 | 0 | 0.3 | 0.1 | 0.2 | 0 |
| Income Before Tax
| -184.319 | -391.5 | -14 | 48.7 | -304.9 | -177.2 | -271.924 | -73.5 | -138 | -171 | -104.218 | -37.213 | -24.233 | -11.98 | -30.054 | -39.917 | -267.859 | -0.648 | -0.186 | -1.926 | -5.793 | -10.358 | -8.867 | -7.07 | 0 | -2.7 | -3.2 | -2.8 | 0 |
| Income Before Tax Ratio
| -0.213 | -0.39 | -0.008 | 0.034 | -0.338 | -0.179 | -0.281 | -0.06 | -0.281 | -1.877 | -1.08 | -0.791 | -0.866 | -0.42 | -2.286 | -4.228 | -316.244 | 0 | 0 | 0 | -445.615 | -18.431 | -6.652 | -8.173 | 0 | -2.25 | -32 | -28 | 0 |
| Income Tax Expense
| 4.437 | -63.5 | 15.5 | 17.6 | 7.1 | -38.7 | 18.855 | -56.1 | -113.7 | 0.024 | 1.672 | -9.626 | -19.358 | -0.018 | -0.294 | -0.083 | -0.083 | 0.238 | 0.234 | 0.223 | 0.207 | 1.338 | -0.082 | 0.095 | 0.206 | -0.3 | 0 | -0.1 | 0.5 |
| Net Income
| -188.863 | -328 | -29.5 | 30.586 | -312 | -153 | -305.25 | -25.1 | -30 | -171.7 | -114.407 | -29.048 | -1.283 | -18.926 | -30.113 | -39.834 | -268.405 | -0.648 | -0.186 | -1.926 | -5.793 | -10.358 | -8.785 | -7.165 | -4.357 | -2.7 | -3.3 | -2.9 | -2.7 |
| Net Income Ratio
| -0.219 | -0.327 | -0.017 | 0.021 | -0.346 | -0.154 | -0.316 | -0.021 | -0.061 | -1.885 | -1.185 | -0.617 | -0.046 | -0.664 | -2.29 | -4.22 | -316.889 | 0 | 0 | 0 | -445.615 | -18.431 | -6.59 | -8.283 | -3.169 | -2.25 | -33 | -29 | -27 |
| EPS
| -0.25 | -0.46 | -0.046 | 0.048 | -0.52 | -0.27 | -0.55 | -0.05 | -0.062 | -0.41 | -0.32 | -0.098 | -0.005 | -0.074 | -0.13 | -0.21 | -2.08 | -0.04 | -0.011 | -0.12 | -0.37 | -0.66 | -0.56 | -0.5 | -0.42 | -0.28 | -0.4 | -0.42 | -0.53 |
| EPS Diluted
| -0.25 | -0.46 | -0.046 | 0.048 | -0.52 | -0.27 | -0.55 | -0.05 | -0.06 | -0.41 | -0.32 | -0.098 | -0.005 | -0.074 | -0.13 | -0.21 | -2.08 | -0.04 | -0.011 | -0.12 | -0.37 | -0.66 | -0.56 | -0.5 | -0.42 | -0.28 | -0.4 | -0.42 | -0.53 |
| EBITDA
| -52.76 | -178.3 | 2.6 | 106.1 | -54.3 | -93.3 | -166.705 | 25.1 | -98.5 | -145.8 | -31.764 | -24.863 | -19.071 | -8.085 | -18.785 | -33.944 | 221.297 | -1.117 | -2.499 | -2.046 | -1.444 | -6.542 | -10.506 | -8.314 | -3.951 | -3.2 | -3.3 | -3.1 | -1.5 |
| EBITDA Ratio
| -0.061 | -0.178 | 0.001 | 0.074 | -0.06 | -0.094 | -0.173 | 0.021 | -0.2 | -1.6 | -0.329 | -0.529 | -0.682 | -0.284 | -1.429 | -3.596 | 261.272 | 0 | 0 | 0 | -111.077 | -11.641 | -7.881 | -9.612 | -2.873 | -2.667 | -33 | -31 | -15 |